Skip to main content
Erschienen in: Abdominal Radiology 1/2019

09.07.2018

Association of qualitative and quantitative imaging features on multiphasic multidetector CT with tumor grade in clear cell renal cell carcinoma

verfasst von: Heidi Coy, Jonathan R. Young, Michael L. Douek, Alan Pantuck, Matthew S. Brown, James Sayre, Steven S. Raman

Erschienen in: Abdominal Radiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to determine if enhancement features and qualitative imaging features on multiphasic multidetector computed tomography (MDCT) were associated with tumor grade in patients with clear cell renal cell carcinoma (ccRCC).

Methods

In this retrospective, IRB approved, HIPAA-compliant, institutional review board-approved study with waiver of informed consent, 127 consecutive patients with 89 low grade (LG) and 43 high grade (HG) ccRCCs underwent preoperative four-phase MDCT in unenhanced (UN), corticomedullary (CM), nephrographic (NP), and excretory (EX) phases. Previously published quantitative (absolute peak lesion enhancement, absolute peak lesion enhancement relative to normal enhancing renal cortex, 3D whole lesion enhancement and the wash-in/wash-out of enhancement within the 3D whole lesion ROI) and qualitative (enhancement pattern; presence of necrosis; pattern of; tumor margin; tumor–parenchymal interface, tumor–parenchymal interaction; intratumoral vascularity; collecting system infiltration; renal vein invasion; and calcification) assessments were obtained for each lesion independently by two fellowship-trained genitourinary radiologists. Comparisons between variables included χ2, ANOVA, and student t test. p values less than 0.05 were considered to be significant. Inter-reader agreement was obtained with the Gwet agreement coefficient (AC1) and standard error (SE) was reported.

Results

No significant differences were observed between the LG and HG ccRCC cohorts with respect to absolute peak lesion enhancement and relative lesion enhancement ratio. There was a significant inverse correlation between low and high grade ccRCC and tumor enhancement the NP (71 HU vs. 54 HU, p < 0.001) and EX (52 HU vs. 39 HU, p < 0.001) phases using the 3D whole lesion ROI method. The percent wash-in of 3D enhancement from the UN to the CM phase was also significantly different between LG and HG ccRCCs (352% vs. 255%, p = 0.003). HG lesions showed significantly more calcification, necrosis, collecting system infiltration and ill-defined tumor margins (p < 0.05). Overall agreement between the two readers had a mean AC1 of 0.8172 (SE 0.0235).

Conclusions

Quantitatively, high grade ccRCC had significantly lower whole lesion enhancement in the NP and EX phases on MDCT. Qualitatively, high grade ccRCC were significantly more likely to be associated with calcifications, necrosis, collecting system infiltration, and an ill-defined tumor margin.
Literatur
2.
Zurück zum Zitat Lam JS, Shvarts O, Leppart JT, et al. (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174:466–472CrossRefPubMed Lam JS, Shvarts O, Leppart JT, et al. (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174:466–472CrossRefPubMed
3.
Zurück zum Zitat Sun M, Shariat SF, Cheng C, et al. (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60(4):644–661CrossRefPubMed Sun M, Shariat SF, Cheng C, et al. (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60(4):644–661CrossRefPubMed
4.
Zurück zum Zitat Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663CrossRefPubMed Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663CrossRefPubMed
5.
Zurück zum Zitat Delahunt B, Egevad L, Montironi R, et al. (2013) International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol 37:1463–1468CrossRefPubMed Delahunt B, Egevad L, Montironi R, et al. (2013) International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol 37:1463–1468CrossRefPubMed
6.
Zurück zum Zitat Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275(1):28–42CrossRefPubMed Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275(1):28–42CrossRefPubMed
7.
Zurück zum Zitat Lebret T, Poulain JE, Molinie V, et al. (2007) Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178(4 Pt 1):1184–1188 (discussion 1188. 75)CrossRefPubMed Lebret T, Poulain JE, Molinie V, et al. (2007) Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178(4 Pt 1):1184–1188 (discussion 1188. 75)CrossRefPubMed
8.
Zurück zum Zitat Leveridge MJ, Finelli A, Kachura JR, et al. (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60(3):578–584CrossRefPubMed Leveridge MJ, Finelli A, Kachura JR, et al. (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60(3):578–584CrossRefPubMed
9.
Zurück zum Zitat Halverson SJ, Kunju LP, Bhalla R, et al. (2013) Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol 189(2):441–446CrossRefPubMed Halverson SJ, Kunju LP, Bhalla R, et al. (2013) Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol 189(2):441–446CrossRefPubMed
10.
Zurück zum Zitat Ball MW, Bezerra SM, Gorin MA, et al. (2015) Grade heterogeneity in small renal masses: potential implications for renal mass biopsy. J Urol 193(1):36–40CrossRefPubMed Ball MW, Bezerra SM, Gorin MA, et al. (2015) Grade heterogeneity in small renal masses: potential implications for renal mass biopsy. J Urol 193(1):36–40CrossRefPubMed
11.
Zurück zum Zitat Gerlinger Rowan, Horswell S, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892CrossRefPubMedPubMedCentral Gerlinger Rowan, Horswell S, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Jamshidi N, Jonasch E, Zapala M, et al. (2015) The radiogenomic risk score: construction of a prognostic quantitative, noninvasive image-based molecular assay for renal cell carcinoma. Radiology 277:114–123CrossRefPubMed Jamshidi N, Jonasch E, Zapala M, et al. (2015) The radiogenomic risk score: construction of a prognostic quantitative, noninvasive image-based molecular assay for renal cell carcinoma. Radiology 277:114–123CrossRefPubMed
13.
Zurück zum Zitat Lubner M, Stabo N, Abel EJ, Munoz del Rio A, Pickhardt PCT (2016) Textural analysis of large primary renal cell carcinomas: pretreatment tumor heterogeneity correlates with histologic findings and clinical outcomes. AJR 207:96–105CrossRefPubMed Lubner M, Stabo N, Abel EJ, Munoz del Rio A, Pickhardt PCT (2016) Textural analysis of large primary renal cell carcinomas: pretreatment tumor heterogeneity correlates with histologic findings and clinical outcomes. AJR 207:96–105CrossRefPubMed
15.
Zurück zum Zitat Shinagare A, Krajewski K, Braschi-Amirfarzan M, Ramaiya N (2017) Advanced renal cell carcinoma: role of the radiologist in the era of precision medicine. Radiology 284(2):333–351CrossRefPubMed Shinagare A, Krajewski K, Braschi-Amirfarzan M, Ramaiya N (2017) Advanced renal cell carcinoma: role of the radiologist in the era of precision medicine. Radiology 284(2):333–351CrossRefPubMed
16.
Zurück zum Zitat Ishigami K, Leite L, Pakalniskis M, et al. (2014) Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomomgraphy. SpringerPlus 3:694CrossRefPubMedPubMedCentral Ishigami K, Leite L, Pakalniskis M, et al. (2014) Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomomgraphy. SpringerPlus 3:694CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. Am J Roentgenol 195:W344–W351CrossRef Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. Am J Roentgenol 195:W344–W351CrossRef
18.
Zurück zum Zitat Reiner C, Roessle M, Thiesler T, et al. (2013) Computed tomography perfusion imaging of renal cell carcinoma. Invest Radiol 48:183–191PubMed Reiner C, Roessle M, Thiesler T, et al. (2013) Computed tomography perfusion imaging of renal cell carcinoma. Invest Radiol 48:183–191PubMed
19.
Zurück zum Zitat Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24(6):835–842CrossRefPubMed Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24(6):835–842CrossRefPubMed
20.
Zurück zum Zitat Villalobos-Gollas M, Aguilar-Davidov B, Culebro-Garcia C, et al. (2012) Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal cell carcinoma: additional information for selecting candidates for surveillance protocols. Int Urol Nephrol 44:1369–1374CrossRefPubMed Villalobos-Gollas M, Aguilar-Davidov B, Culebro-Garcia C, et al. (2012) Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal cell carcinoma: additional information for selecting candidates for surveillance protocols. Int Urol Nephrol 44:1369–1374CrossRefPubMed
21.
Zurück zum Zitat Yuan Q, Kapur P, Zhang Y (2016) Intratumor heterogeneity of perfusion and diffusion in clear-cell renal cell carcinoma: correlation with tumor cellularity. Clin Genitourin Cancer 14(6):e585–e594CrossRefPubMedPubMedCentral Yuan Q, Kapur P, Zhang Y (2016) Intratumor heterogeneity of perfusion and diffusion in clear-cell renal cell carcinoma: correlation with tumor cellularity. Clin Genitourin Cancer 14(6):e585–e594CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Vargas H, Delany H, Delappe E, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMed Vargas H, Delany H, Delappe E, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMed
23.
Zurück zum Zitat Frank I, Blute ML, Cheville JC, et al. (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168(6):2395–2400CrossRefPubMed Frank I, Blute ML, Cheville JC, et al. (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168(6):2395–2400CrossRefPubMed
24.
Zurück zum Zitat Leibovich BC, Blute ML, Cheville JC, et al. (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671CrossRefPubMed Leibovich BC, Blute ML, Cheville JC, et al. (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671CrossRefPubMed
25.
Zurück zum Zitat Sahni VA, Silverman SG (2014) Imaging management of incidentally detected small renal masses. Semin Interv Radiol 31(1):9–19CrossRef Sahni VA, Silverman SG (2014) Imaging management of incidentally detected small renal masses. Semin Interv Radiol 31(1):9–19CrossRef
26.
Zurück zum Zitat Coy H, Young JR, Douek M, et al. (2017) Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. Abdom Radiol 42(7):1919–1928CrossRef Coy H, Young JR, Douek M, et al. (2017) Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. Abdom Radiol 42(7):1919–1928CrossRef
27.
Zurück zum Zitat Zhu YH, Wang X, Zhang J, et al. (2014) Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high grade tumor of clear cell renal cell carcinoma. Am J Roentgenol 203:W295–W300CrossRef Zhu YH, Wang X, Zhang J, et al. (2014) Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high grade tumor of clear cell renal cell carcinoma. Am J Roentgenol 203:W295–W300CrossRef
28.
Zurück zum Zitat Huhdanpaa H, Hwang D, Cen S, et al. (2015) CT prediction of the Fuhrman grade of clear cell renal cell carcinoma (RCC): towards the development of computer-assisted diagnostic method. Abdom Imaging 40(8):3168–3174CrossRefPubMed Huhdanpaa H, Hwang D, Cen S, et al. (2015) CT prediction of the Fuhrman grade of clear cell renal cell carcinoma (RCC): towards the development of computer-assisted diagnostic method. Abdom Imaging 40(8):3168–3174CrossRefPubMed
29.
Zurück zum Zitat Kopp RP, Aganovic L, Palazzi KL, et al. (2013) Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. Can J Urol 20(3):6790–6797PubMed Kopp RP, Aganovic L, Palazzi KL, et al. (2013) Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. Can J Urol 20(3):6790–6797PubMed
30.
Zurück zum Zitat Sun M, Lughezani G, Jeldres C, et al. (2009) A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 56:775–781CrossRefPubMed Sun M, Lughezani G, Jeldres C, et al. (2009) A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 56:775–781CrossRefPubMed
31.
Zurück zum Zitat Oh S, Sung DJ, Yang KS, et al. (2017) Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma. Acta Radiol 58(3):376–384CrossRefPubMed Oh S, Sung DJ, Yang KS, et al. (2017) Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma. Acta Radiol 58(3):376–384CrossRefPubMed
32.
Zurück zum Zitat Frank I, Blute ML, Cheville JC, et al. (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168:2395–2400CrossRefPubMed Frank I, Blute ML, Cheville JC, et al. (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168:2395–2400CrossRefPubMed
33.
Zurück zum Zitat Vargas H, Delany H, Delappe E, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for assessment of renal clear-cell carcinoma Fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMed Vargas H, Delany H, Delappe E, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for assessment of renal clear-cell carcinoma Fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMed
Metadaten
Titel
Association of qualitative and quantitative imaging features on multiphasic multidetector CT with tumor grade in clear cell renal cell carcinoma
verfasst von
Heidi Coy
Jonathan R. Young
Michael L. Douek
Alan Pantuck
Matthew S. Brown
James Sayre
Steven S. Raman
Publikationsdatum
09.07.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 1/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1688-8

Weitere Artikel der Ausgabe 1/2019

Abdominal Radiology 1/2019 Zur Ausgabe

Classics in Abdominal Radiology

Target sign: appendicitis

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.